Heavy cannabis use linked to urinary tract problems in young adults

Association Between Cannabis Use Disorder and Lower Urinary Tract Symptoms in Young Adults: A Nationwide Claims Database Study.

Urology • • Moderately Relevant
🤖

AI Summary

This large-scale database study examined the relationship between Cannabis Use Disorder (CUD) and lower urinary tract symptoms (LUTS) in over 168,000 young adults aged 18-34. Researchers used propensity score matching to compare health outcomes between individuals with CUD and matched controls over a 5-year period. The findings reveal a significant association: individuals with CUD had 69% higher risk in males and 81% higher risk in females of developing new-onset LUTS compared to their peers without CUD.

The study identified increased risks for multiple specific urinary conditions among CUD patients, including dysuria (painful urination), pelvic/perineal pain, and urinary tract infections in both men and women. Notably, the research found no significant association between CUD and overactive bladder (OAB), suggesting that cannabis-related urinary issues may involve specific mechanisms rather than affecting all lower urinary tract functions equally. These findings were statistically significant across all measured groups.

The research highlights an important but understudied health consequence of regular cannabis use in young adults. While the study establishes a clear association between CUD and LUTS, the authors emphasize that further research is needed to understand the specific mechanisms by which cannabinoids affect lower urinary tract function. This work contributes to growing evidence that heavy cannabis use may carry risks beyond psychiatric or respiratory concerns, particularly relevant for young people with developing habits.

📄 Original Abstract

To investigate the association of Cannabis Use Disorder (CUD) with new diagnoses of lower urinary tract symptoms (LUTS) in a young adult cohort. Using the TriNetX database, we identified patients aged 18-34 and stratified by sex and CUD diagnosis into cohorts. Propensity score matching was utilized on demographics and variables potentially affecting LUTS. The primary outcomes were 5-year risks of new onset lower urinary tract diagnoses, including all-cause LUTS, dysuria, pelvic/perineal pain, overactive bladder (OAB), and urinary tract infection (UTI), among patients with CUD compared to controls. We identified 101,761 and 67,110 matched pairs of males and females, respectively. At 5-year follow-up, CUD was associated with a higher risk of new onset of all-cause LUTS in males (RR 1.69, 95% CI 1.60-1.80, p<0.01) and females (RR 1.81, 95% CI 1.73-1.89, p<0.01) compared to controls. Increased risks of dysuria, pelvic/perineal pain, and UTI were observed in both male and female CUD patients compared to controls (all p<0.01). CUD was not associated with OAB in either males or females. In a cohort of young adults, CUD was associated with a greater risk of developing LUTS in both men and women. Further research is needed to define the impact of cannabinoids on lower urinary tract function.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.